Cite
HARVARD Citation
Tatsukawa, Y. et al. (2018). Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: A pilot study. Antiviral therapy. 23 (8), pp. 639-646. [Online].